(Q36151567)

12 August 2017

Probiotics, symptoms, and gut microbiota: what are the relations? A randomized controlled trial in subjects with irritable bowel syndrome (English)

1 reference

12 August 2017

0 references

irritable bowel syndrome

1 reference

1

Per G Farup

1 reference

12 August 2017

Morten Jacobsen

2

1 reference

12 August 2017

Solveig C Ligaarden

series ordinal

3

1 reference

12 August 2017

Knut Rudi

series ordinal

4

1 reference

12 August 2017

language of work or name

1 reference

31 July 2012

1 reference

Gastroenterology research and practice

12 August 2017

1 reference

12 August 2017

2012

1 reference

12 August 2017

214102

1 reference

Creative Commons Attribution 3.0 Unported

12 August 2017

start time

1 January 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Review article: probiotics for the treatment of irritable bowel syndrome--focus on lactic acid bacteria.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3415104

Irritable bowel syndrome, gut microbiota and probiotics.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3415104

Probiotics, nuclear receptor signaling, and anti-inflammatory pathways

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3415104

Effect of a multispecies probiotic supplement on quantity of irritable bowel syndrome-related intestinal microbial phylotypes

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3415104

A candidate probiotic with unfavourable effects in subjects with irritable bowel syndrome: a randomised controlled trial

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3415104

Inflammatory bowel disease, gut bacteria and probiotic therapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3415104

A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3415104

The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3415104

Review article: probiotics and prebiotics in irritable bowel syndrome

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3415104

Gastrointestinal microbiota in irritable bowel syndrome: their role in its pathogenesis and treatment

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3415104

The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3415104

Multivariate analysis of complex DNA sequence electropherograms for high-throughput quantitative analysis of mixed microbial populations

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3415104

Comparison of chicken gut colonisation by the pathogens Campylobacter jejuni and Clostridium perfringens by real-time quantitative PCR.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3415104

Application of measurements of transepithelial electrical resistance of intestinal epithelial cell monolayers to evaluate probiotic activity

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3415104

A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3415104

Identification of potential probiotic starter cultures for Scandinavian-type fermented sausages

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3415104

Do interventions which reduce colonic bacterial fermentation improve symptoms of irritable bowel syndrome?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3415104

Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3415104

A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome.

2 October 2017

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F214102

Lactobacillus plantarum prevents the upregulation of adhesion molecule expression in an experimental colitis model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F214102

Lactobacillus plantarum ameliorates colonic epithelial barrier dysfunction by modulating the apical junctional complex and PepT1 in IL-10 knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F214102

An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F214102

Distinct microbial populations exist in the mucosa-associated microbiota of sub-groups of irritable bowel syndrome

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22899904

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22899904

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22899904

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1155/2012/214102

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

22899904

1 reference